中台灣區域教學醫院2020年使用不同新冠檢測平台的經驗

根據WHO的最新統計數據，從2019年12月直至2021年8月中，全球多達2.16億人被診斷出新冠病毒（COVID-19），導致近450萬人死亡。COVID-19檢驗是防疫最重要的一個關卡。本研究使用之檢體為公費或自費檢驗COVID-19需求者。檢驗方法：1.指定檢驗機構檢驗方法（LDT）、2.瑞基新型冠狀病毒檢測。秀傳紀念醫院從2020年4月29日開始提供體系三院區COVID-19檢測服務，至2020年底，共執行3381件的檢測。秀傳公費送驗檢體共1793件，男性占比65.81%、女性占34.19%；本國籍佔62.41%、外國籍佔37.59%；主要送驗單位為急診及感染科。自費檢驗共1147件，男性占72.10%、女性占27.90%；年齡主要分布在20-50歲的勞動年齡，自費受檢因素大多為工作需求。我們使用兩種檢測平台，其中以LTD方式的有2325件，瑞基有1056件；LDT有疑似無法判定的發生機率為1.8%；瑞基檢測無法判定的發生率為1.0%。目前因應COVID-19的篩選平台已經越來越多，每個平台各有其優缺點及適合的時機；LTD適合確診案例或檢體量多；而瑞基適合急件時篩檢。本研究統計2020年成立至年底兩個平台的使用經驗，供其他單位參考。

關鍵字

新型冠狀病毒；指定檢驗機構檢驗方法；瑞基新型冠狀病毒檢測

並列摘要

Globally, the World Health Organization (WHO) has reported 216 million confirmed cases of COVID-19, including 4.5 million deaths. The diagnosis of COVID-19 is the most important method to prevent the epidemic. In this study, clinical samples were tested for COVID-19 at Show Chwan Memorial Hospital from April 29, 2020 to December 31, 2020. Two detection platforms were used: LTD, and POCKIT (ii RT-PCR). As a result, a total of 3381 COVID-19 diagnostic tests were performed, of which 1793 diagnostic tests of notifiable infectious diseases. Of the 3381 tests, 72.1% were conducted in men and 27.9% in women, and 65.8% were performed in Taiwanese subjects, and 34.2% in foreign subjects. Most of the samples came from the emergency and infection departments. A total of 1147 self-financed screening were conducted, of which 72.1% were conducted in men and 27.9% in women. Most of the people tested were of working age (20-50 years), and most tests were conducted due to employment requirements. Of the 3381 tests, 2307 were conducted using LTD, and 1072 using POCKIT (ii RT-PCR). The rates of indeterminate results for LDT and POCKIT (ii RT-PCR) were 1.8% and 0.9%, respectively. In conclusion, there are an increasing number of screening platforms for COVID-19, and each has its advantages and disadvantages. LTD is suitable for confirmed cases or large numbers of examinations, and POCKIT (ii RT-PCR) is suitable for screening in urgent cases. The prices of instruments and reagents also determine the selection of the testing method.

並列關鍵字

COVID-19 ； Laboratory-developed assay(LDT) ； POCKIT (ii RT-PCR)

主題瀏覽